Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With Ocrelizumab
Article in Neurology and Therapy (July 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Neurology and Therapy (July 2023)
Article in Neurology and Therapy (May 2022)
Article in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery (February 2021)